Welcome to Omnimabs!
TEL: 02154156726 Info: info@Omnimabs.com

MAP2K2 antibody - C-terminal region

Catalog Number:OM113464
OM113464
Discount Price
OM113464-100ul
1~2 Week
100ul
OM113464-50ul
50ul
OM113464-20ul
20ul
1~2 Week
Product Profile
Product Name MAP2K2 antibody - C-terminal region
Antibody Type Primary Antibodies
Immunogen The immunogen for anti-MAP2K2 antibody: synthetic peptide directed towards the C terminal of human MAP2K2
Key Feature
Clonality Polyclonal
Isotype IgG
Host Species Rabbit
Tested Applications WB,IHC
Species Reactivity Bovine,Guinea Pig,Horse,Human,Mouse,Pig,Rat
Concentration 1mg/ml
Purification Affinity purified
Target Information
Gene Symbol MAP2K2
Gene Synonyms MAPKK2
MEK2
MKK2
PRKMK2
Gene Full Name Mitogen-activated protein kinase kinase 2
Gene Summary MAP2K2 is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in MAP2K2 gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene.The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative Names MAPKK2
MEK2
MKK2
PRKMK2
Molecular Weight(MW) 44kDa
Sequence 400 amino acids
Database Links
Entrez Gene 5605
SwissProt ID P36507
Protein Accession NP_109587
Application

Western blot

0.2-1 ug/ml
Positive Control: HepG2 cell lysate

Immunohistochemical

Additional Information
Form Liquid
Storage Instructions Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles
Storage Buffer phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
validation
question title
question detaiil
Verification code